Biosimilar im Vergleich zu DRUGDOCS Nutzung und Statistiken

Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics. ** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
  • Apple App Store
  • Bezahlt
  • Medizin

Rang speichern

- -

DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

Biosimilarvs. DRUGDOCS Ranking-Vergleich

Vergleichen Sie Biosimilar den Ranking-Trend der letzten 28 Tage mit DRUGDOCS

BiosimilarBiosimilar#132

Rang

Biosimilar im Vergleich zu DRUGDOCS Ranking im Ländervergleich

Vergleichen Sie Biosimilar den Ranking-Trend der letzten 28 Tage mit DRUGDOCS

Alle Kategorien

Keine Daten verfügbar

Medizin

App
Top-Land
Rang
#132
- -
- -

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
Biosimilar VS.
DRUGDOCS

Dezember 19, 2024